CN Stock MarketDetailed Quotes

Xiangxue Pharmaceutical (300147)

Watchlist
  • 10.02
  • +0.61+6.48%
Market Closed Apr 30 15:00 CST
6.63BMarket Cap-4.68P/E (TTM)

Xiangxue Pharmaceutical (300147) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Traditional Chinese medicine978.51M61.33%
Other389.6M24.42%
Antivirus oral liquid139.48M8.74%
Orange series87.81M5.50%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Traditional Chinese medicine978.51M61.33%
Pharmaceutical manufacturing282.65M17.72%
Other282.09M17.68%
Pharmaceutical circulation33.34M2.09%
medical apparatus18.82M1.18%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
North, East and Northeast China1.06B66.21%
Guangdong province387.16M24.27%
Central China89.41M5.60%
Southwest region62.56M3.92%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More